CABLIVI® Patient Support
Find the access, education, and ongoing support you need from Sanofi for your aTTP/iTTP* journey with CABLIVI (caplacizumab-yhdp).
*aTTP is also known as iTTP. You and your healthcare team can use either term.
Keep moving forward with HemAssist
HemAssist provides you with support from the moment you enroll, whether that’s navigating insurance coverage or providing supplemental training on how to inject at home. After you enroll, your HemAssist team will reach out to welcome you to the program and explain what to expect. Save 1-833-723-5463 to your contacts. Learn how to enroll
OUR SUPPORT
Affording CABLIVI
No matter your situation, we are committed to helping you access and afford treatment. Your team will verify your insurance coverage and determine what financial assistance programs you may be eligible for.
Starting treatment
Your team can help you get started with CABLIVI right away. We'll provide supplemental training on how to inject, answer questions about aTTP/iTTP, and help you navigate insurance coverage questions.
Ongoing support
Our team provides support and guidance throughout your journey with CABLIVI. This includes helping you stay with treatment as prescribed, navigating insurance, and more.
Financial assistance
Whether you have commercial insurance, government insurance, or are experiencing a gap in insurance, our team is here to help. If you need help paying for medication, we can help determine if you may be eligible for financial assistance.
Copay Assistance Program*
If you have commercial insurance (insurance sponsored by your employer or private insurance) and you’re having trouble paying for your medication, HemAssist’s Copay Assistance Program* may be able to help. Get your treatment for as little as $0.
Patient Assistance Program†
If you have government insurance, including Medicare, Medicaid, or insurance obtained through the Healthcare Marketplace, HemAssist’s Patient Assistance Program may be available to help eligible uninsured and underinsured patients.
*Not valid for CABLIVI prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DoD, TRICARE®, or similar federal or state programs including any state pharmaceutical assistance programs. Not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Copay Program at any time without notice. Savings may vary depending on the patient’s out-of-pocket costs. Upon registration, the patient will receive all program details.
Approval is not guaranteed. Sanofi reserves the right to modify or discontinue the programs at any time. Terms and conditions apply.
† Claims for free products dispensed through the Patient Assistance Program shall not be submitted to any third-party payer, public or private (e.g. private insurance, Medicaid, Medicare, VA, DoD, TRICARE®, or similar federal or state programs) for reimbursement. All Programs not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Programs at any time without notice. Program details provided upon registration.
Getting started
You will receive two doses of CABLIVI on day 1. Your care team will give the first dose of CABLIVI through an IV injection before your first plasma exchange session. After your plasma exchange session, they will give the second dose of CABLIVI as an injection into the skin of your stomach.
You will continue to receive a dose of CABLIVI every day you receive plasma exchange, and for at least 30 days after, even when you return home. Your HemAssist team will provide supplement training to inject CABLIVI with confidence at home.
Your doctor may decide you need to take CABLIVI for more than 30 days. This additional period may last up to 28 days.
RESOURCES FOR STARTING CABLIVI
Take on aTTP with CABLIVI Confidence
How to self-administer
How to take CABLIVI
The Language of aTTP/iTTP
Support along the way
Living with aTTP/iTTP can be a complex path to follow. But you’re not alone. Our dedicated HemAssist team is here to help. We’ll work with you one-to-one to help you start CABLIVI and stay with treatment as you return home.
MEET YOUR TEAM
Clinical Educator (CE)
Your dedicated Clinical Educator is your point of contact for questions and tips about CABLIVI, supplemental injection training, and ongoing support.
Your Clinical Educator will not provide personal medical advice. For all questions about your individual health needs, consult with your treating physician.
Case Manager
Your Case Manager is available to assist with navigating insurance coverage and identifying available financial support for eligible patients.
REASONS TO REACH OUT
Your Clinical Educator and Case Manager are available to assist you at any point along your CABLIVI journey.
Your Clinical Educator can provide supplemental injection training support along with helpful tips about building a treatment routine. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.
When you change or start new insurance, you may have questions about affording CABLIVI. Contact your Case Manager for help navigating the process. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.
Your team can help you navigate life changes such as choosing or changing insurance for the first time. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.
Starting a new treatment takes dedication. Your Clinical Educator can help with tips for building your treatment routine and help maintaining motivation when you need it. Call 1-833-723-5463 Monday – Friday 8 AM to 7 PM ET.
Resources from the community
Ree Wynn Foundation
National Organization for Rare Disorders (NORD)
Platelet Disorder Support Association
This listing is provided as a resource only and does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources on this topic may be available and should be investigated. Sanofi does not review or control the content of non-Sanofi websites.
Who should not take CABLIVI?
Do not take CABLIVI if you’ve had an allergic reaction to caplacizumab-yhdp or to any of the ingredients in CABLIVI.
What should I tell my healthcare team before starting CABLIVI?
Tell your doctor if you have a medical condition including if you have a bleeding disorder. Tell your doctor about any medicines you take, including medicines that increase your risk of bleeding such as anti-coagulants and anti-platelet agents.
Talk to your doctor before scheduling any surgery, medical or dental procedure.
What are the possible side effects of CABLIVI?
CABLIVI can cause severe bleeding. In clinical studies, severe bleeding adverse reactions of nosebleed, bleeding from the gums, bleeding in the stomach or intestines, and bleeding from the uterus were each reported in 1% of subjects. In the post-marketing setting, cases of life-threatening and fatal bleeding were reported in patients receiving CABLIVI. Contact your doctor immediately if symptoms of excessive bruising, excessive bleeding, or major bleeding occur. Signs and symptoms of bleeding include: pain, swelling or discomfort, prolonged bleeding from cuts, increased menstrual flow or vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or dark brown urine, red or tar black stools, headache, dizziness, or weakness.
You may have a higher risk of bleeding if you have a bleeding disorder (i.e. hemophilia) or if you take other medicines that increase your risk of bleeding such as anti-coagulants and anti-platelet agents.
CABLIVI should be stopped for 7 days before surgery or any medical or dental procedure. Talk to your doctor before you stop taking CABLIVI.
The most common side effects include nosebleed, headache and bleeding gums.
Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of CABLIVI. Call your doctor for medical advice about side effects.
What is CABLIVI?
CABLIVI (caplacizumab-yhdp) is a prescription medicine used for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.